At a glance
Selected acute human studies examine GH-axis mechanism, EEG sleep stages and route-dependent endocrine responses. None of these endpoints establishes a muscle or strength benefit.
Identity & scope
The cited material is the named GH-releasing peptide GHRP-6. Similar GH-axis activity does not make other GHRPs interchangeable.
What the research shows
- A receptor-axis experiment can show how a hormone response depends on another signal. It cannot show that changing the signal improves a person’s performance.
Critical interpretation
Separate a mechanistic test from a sleep outcome
The antagonist experiment supports a role for endogenous GHRH in the acute GH response. The sleep-laboratory experiment asks a different question and records stage 2 sleep alongside GH, ACTH and cortisol. Slow-wave sleep did not increase in that experiment. A change in one EEG stage cannot establish improved insomnia, restorative sleep or next-day functioning, and the accompanying adrenal-hormone changes mean the response should not be described as selectively releasing GH. [1] [2]
Route-specific findings include null results and trends
The later study compared specified oral, nasal and sublingual preparations under placebo conditions. Results varied by route; several reported differences were trends rather than statistically established effects. This is useful evidence against collapsing all delivery formats into a single outcome claim. It also prevents a significant GH result in the nasal arm from being presented as a demonstrated sleep benefit. The study concerns its own preparations and experimental schedule, not every spray carrying the GHRP-6 name. [3]
Limitations & uncertainties
- Only nine healthy men were studied in this experiment.
- The results do not establish effects of long-term exposure, a nasal formulation or a supplier product.
Open research questions
- Which functional endpoint, beyond a circulating hormone marker, would test the proposed hypothesis?
- What is the exact material specification and how does it relate to the cited preparation?
Selected papers & source records
Download bibliography1. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation (opens in a new tab)
Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA. (1998). Journal of Clinical Endocrinology & Metabolism. DOI: 10.1210/jcem.83.4.4711 (opens in a new tab) · PMID 9543138
- Design & population
- Physiological challenge experiment in nine healthy men, comparing GHRP-6 responses with and without a GHRH antagonist.
- What the study found
- Blocking GHRH removed most of the GH response to GHRP-6, supporting a role for endogenous GHRH in that response.
- Limits on interpretation
- An acute endocrine mechanism experiment, not a trial of strength, recovery, weight control or nasal products.
2. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man (opens in a new tab)
Frieboes RM, Murck H, Maier P, et al. (1995). Neuroendocrinology. DOI: 10.1159/000126883 (opens in a new tab) · PMID 7617137
- Design & population
- Placebo-comparison sleep-laboratory experiment in healthy men, combining overnight EEG with GH, ACTH and cortisol measurements.
- What the study found
- Stage 2 sleep increased, but slow-wave sleep and other sleep-EEG variables did not. ACTH and cortisol rose alongside GH.
- Limits on interpretation
- Acute experimental sleep architecture and hormone measurements, without an insomnia-treatment or next-day-function outcome. The response was not GH-selective.
3. Effects of growth hormone-releasing peptide-6 on the nocturnal secretion of GH, ACTH and cortisol and on the sleep EEG in man: role of routes of administration (opens in a new tab)
Frieboes RM, Murck H, Antonijevic IA, Steiger A. (1999). Journal of Neuroendocrinology. DOI: 10.1046/j.1365-2826.1999.00364.x (opens in a new tab) · PMID 10336729
- Design & population
- Placebo comparisons of oral, intranasal and sublingual experimental GHRP-6 preparations in healthy young men, with overnight EEG and hormone sampling.
- What the study found
- Results differed by route. Intranasal exposure significantly increased GH; several sleep and ACTH findings were only statistical trends. The oral preparation did not increase the measured hormones.
- Limits on interpretation
- Exposure and study conditions differed across routes. Statistical trends should not be reported as demonstrated sleep benefits, and study preparations do not establish catalogue-spray performance.
Search & review scope
Targeted web searches of PubMed-indexed primary research and original journal records. Selected abstracts and citation metadata were checked; full-text sections were consulted for the records explicitly labelled full-text. Retrieved records and targeted notice searches were also checked for visible corrections or retractions.. Checked 9 November 2026.
Selected primary research relevant to the named compound, its molecular specification and the endpoints described below.
Narrative selection, not a systematic review, comprehensive safety assessment or complete retraction audit. PubMed/PMC full-text access was intermittent. An abstract or selected-section review cannot replace appraisal of the complete methods, supplements and underlying data. Absence from this selection does not establish absence of research.
Recorded search terms
- site.pubmed.ncbi.nlm.nih.gov GHRP-6 growth hormone 9543138
- site.pubmed.ncbi.nlm.nih.gov "Growth hormone-releasing peptide-6 stimulates sleep" Frieboes
- "10.1046/j.1365-2826.1999.00364.x" PMID
Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.
Cite this review
HeartPep. GHRP-6: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/ghrp-6.
HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.
Buy from HeartPep.com
Laboratory research only. Not for human or veterinary use.